NCT03607916View on ClinicalTrials.gov

Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery.

PHASE2CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

February 28, 2014

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Pregnant Women
Interventions
DRUG

Hyperbaric prilocaine 2%

Varying dose according to sensitive response of previous subjects. All study doses of hyperbaric prilocaine 2% will be administrated intrathecally with 100µg of morphine

DRUG

Hyperbaric prilocaine 2%

The dose of 60 mg of Hyperbaric prilocaine 2% will be administrated intrathecally with 100µg of morphine

DRUG

Morphine

100µg morphine

Trial Locations (1)

1000

University Hospital Saint-Pierre, Université Libre de Bruxelles, Brussels Capital Region

All Listed Sponsors
lead

Centre Hospitalier Universitaire Saint Pierre

OTHER

NCT03607916 - Estimation of the Effective Dose (ED) 95 of Intrathecal Hyperbaric Prilocaine 2% for Scheduled Cesarean Delivery. | Biotech Hunter | Biotech Hunter